Campbell's (NASDAQ:CPB - Get Free Report) had its target price reduced by research analysts at DA Davidson from $39.00 to $34.00 in a report released on Monday,Benzinga reports. The firm presently has a "neutral" rating on the stock. DA Davidson's target price would indicate a potential downside of 0.61% from the company's previous close.
CPB has been the subject of several other research reports. Consumer Edge restated an "equal weight" rating on shares of Campbell's in a research report on Monday, March 17th. Morgan Stanley dropped their target price on Campbell's from $40.00 to $35.00 and set an "equal weight" rating for the company in a research report on Tuesday, June 3rd. Royal Bank of Canada dropped their target price on Campbell's from $44.00 to $38.00 and set a "sector perform" rating for the company in a research report on Tuesday, June 3rd. Stephens reduced their target price on shares of Campbell's from $48.00 to $43.00 in a research note on Wednesday, May 28th. Finally, JPMorgan Chase & Co. lowered shares of Campbell's from an "overweight" rating to a "neutral" rating and reduced their target price for the company from $48.00 to $37.00 in a research note on Thursday, March 6th. Five analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Campbell's has a consensus rating of "Hold" and a consensus target price of $40.11.
Get Our Latest Report on Campbell's
Campbell's Price Performance
Shares of CPB traded down $0.27 during trading hours on Monday, hitting $34.21. The stock had a trading volume of 878,824 shares, compared to its average volume of 2,889,705. The company's fifty day moving average is $36.09 and its two-hundred day moving average is $38.94. The company has a debt-to-equity ratio of 1.74, a current ratio of 0.91 and a quick ratio of 0.50. Campbell's has a 52 week low of $32.95 and a 52 week high of $52.81. The stock has a market capitalization of $10.20 billion, a price-to-earnings ratio of 18.69, a P/E/G ratio of 2.71 and a beta of 0.11.
Campbell's (NASDAQ:CPB - Get Free Report) last posted its earnings results on Monday, June 2nd. The company reported $0.73 earnings per share for the quarter, topping the consensus estimate of $0.65 by $0.08. Campbell's had a net margin of 5.57% and a return on equity of 23.79%. The business had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. During the same quarter in the prior year, the firm earned $0.75 EPS. The firm's quarterly revenue was up 4.5% compared to the same quarter last year. On average, analysts anticipate that Campbell's will post 3.15 EPS for the current year.
Insiders Place Their Bets
In other Campbell's news, EVP Charles A. Brawley III sold 2,498 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $40.03, for a total transaction of $99,994.94. Following the sale, the executive vice president now directly owns 37,590 shares in the company, valued at approximately $1,504,727.70. This trade represents a 6.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 20.19% of the company's stock.
Institutional Trading of Campbell's
Hedge funds and other institutional investors have recently made changes to their positions in the business. Manchester Capital Management LLC boosted its position in Campbell's by 923.2% during the first quarter. Manchester Capital Management LLC now owns 706 shares of the company's stock valued at $28,000 after purchasing an additional 637 shares during the last quarter. NBC Securities Inc. acquired a new position in Campbell's during the first quarter worth $31,000. Sherman Asset Management Inc. acquired a new position in Campbell's during the fourth quarter worth $36,000. Principal Securities Inc. increased its holdings in Campbell's by 45.5% during the fourth quarter. Principal Securities Inc. now owns 927 shares of the company's stock worth $39,000 after buying an additional 290 shares during the last quarter. Finally, Geneos Wealth Management Inc. increased its holdings in Campbell's by 333.3% during the first quarter. Geneos Wealth Management Inc. now owns 975 shares of the company's stock worth $39,000 after buying an additional 750 shares during the last quarter. 52.35% of the stock is currently owned by institutional investors and hedge funds.
Campbell's Company Profile
(
Get Free Report)
The Campbell's Company, formerly known as Campbell Soup Company, together with its subsidiaries, manufactures and markets food and beverage products in the United States and internationally. The company operates through Meals & Beverages and Snacks segments. The Meals & Beverages segment engages in the retail and foodservice businesses in the United States and Canada.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Campbell's, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Campbell's wasn't on the list.
While Campbell's currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.